Biomet Inc. : BIOMET ANNOUNCES LIFETIME LIMITED IMPLANT REPLACEMENT WARRANTY ON OXFORD® PARTIAL KNEE WHEN IMPLANTED WITH SIGNATURE™* PERSONALIZED PATIENT CARE SYSTEM
09/25/2012| 11:45am US/Eastern
Recommend:
WARSAW, IN, September 24, 2012 - Biomet announced today a
Lifetime Knee Implant Replacement warranty in the U.S.,
covering the Oxford® Partial Knee utilizing
Signature™ technology. With the Lifetime Implant Replacement
Warranty, Biomet will cover the cost of a Biomet replacement
implant for U.S. patients who received the
Oxford® Partial Knee implanted utilizing
Signature™ technology and need revision surgery for any
reason, subject to the terms and conditions of the written
warranty. The warranty is effective for the replacement of
Oxford® Partial Knees implanted utilizing
Signature™ personalized positioning guides in the United
States on or after September 10, 2012. Any additional costs
associated with a replacement surgery beyond the Biomet
replacement implant will not be covered by Biomet.
Biomet President and CEO Jeff Binder stated: "Since our
founding 35 years ago, Biomet has established a heritage of
offering innovative technologies and services that contribute
to the delivery of high-quality, high-value personalized
patient care. We believe that this is the only warranty of
its type in the U.S., and we plan to assess the value of the
program to our customers in a dynamically changing healthcare
environment."
The Lifetime Implant Warranty builds on the proven track
record of the Oxford® Partial
Knee. One published long-term clinical study on the Oxford®
Partial Knee demonstrated a
91% survivorship at 20 years.1
Biomet's Oxford® Partial Knee System is designed
to help surgeons preserve and restore normal knee function
and movement by replacing only the medial, diseased
compartment of the knee. The Oxford® Partial
Knee procedure removes approximately 75% less bone** than a
total knee replacement and has been shown to allow for a more
rapid recovery2
when compared to a total knee replacement. The Signature™
Personalized Patient Care System complements the
Oxford® Partial Knee by providing surgeons with
a technique to perform knee replacement surgery specific to a
patient's anatomy.
Partial knee replacement is intended to preserve healthy knee
structures in patients with limited knee arthritis by
replacing only one side of the knee, and to provide more
natural motion when compared to a total knee
replacement.3,4 Partial knee replacement may
also provide for less pain5 and shorter recovery
periods2 than total knee replacement.
Patient Risk Information
The Oxford® Partial Knee is intended for use in
individuals with osteoarthritis or avascular necrosis limited
to the medial compartment of the knee and is intended to be
implanted with bone cement. The Oxford® Knee is
not indicated for use in the lateral compartment. Potential
risks include, but are not limited to, loosening,
dislocation, fracture, wear and infection, any of which can
require additional surgery. For additional information about
the Signature™ system and the Oxford® Knee,
including risks and warnings, talk to your surgeon and see
the full patient risk information on http://oxfordknee.com.
About Biomet
Biomet, Inc. and its subsidiaries design, manufacture and
market products used primarily by musculoskeletal medical
specialists in both surgical and non-surgical therapy.
Biomet's product portfolio encompasses large joint
reconstructive products, including orthopedic joint
replacement devices, and bone cements and accessories; sports
medicine, extremities and trauma products, including internal
and external orthopedic fixation devices; spine and bone
healing products, including spine hardware, spinal
stimulation devices, and orthobiologics, as well as
electrical bone growth stimulators and softgoods and bracing;
dental reconstructive products; and other products, including
microfixation products and autologous therapies.
Headquartered in Warsaw, Indiana, Biomet and its subsidiaries
currently distribute products in approximately 90 countries.
Contact
For further information contact Bill Kolter, Corporate Vice
President, Government Affairs, Public
Affairs and Corporate Communication, at (574) 372-1535 or bill.kolter@biomet.com
.
*A collaborative partnership with Materialise N.V.
** Biomet internal comparison of bone removal -
Oxford® Knee compared to Vanguard™ Knee
REFERENCES
1. Price AJ, Svard U, A second decade lifetable survival
analysis of the Oxford® unicompartmental knee arthroplasty.
Clinical Orthopedics and Related Research 469(1):174-9, 2011.
2. Lombardi, A, et al., Is Recovery Faster for Mobile-bearing
Unicompartmental than Total Knee
Arthroplasty? Clinical Orthopedics and Related Research.
467:1450-57.2009.
3. Cobb, J, et al., Functional Assessment of knee
arthroplasty using an instrumented treadmill. Imperial
College of London. March 8, 2012 (presentation).
4. Price AJ, et al., Simultaneous in vitro measurement of
patellofemoral kinematics and forces following
Oxford medial unicompartmental knee replacement. JBJS(Br).
2006; 88-B; 12: 1591-1595.
5. Hall et al., Unicompartmental Knee Arthroplasty (Alias
Uni-Knee)-An Overview with Nursing
Implications. Orthopedic Nursing. 2004; 23(3): 163-171.
All trademarks herein are the property of Biomet, Inc., or
its subsidiaries, unless otherwise indicated.
distributed by
|
|
Recommend :
